Mevion Medical CE Marks S250-FIT Proton Therapy System for Global Use
CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems,...
Tag : Healthcare Financing
Astellas & Vir Biotech Team on PRO-XTEN® VIR-5500 Cancer Drug
– Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues – – Astellas to lead commercialization of VIR-5500 in...
Frontier Biotech & GSK License siRNA Therapeutics Globally
Frontier Biotechnologies Inc. (hereinafter referred to as “Frontier Biotech” or “the Company”) has entered into an exclusive licensing agreement with GSK, a global biopharma company. Under the...
Virion Reports Phase 1b Anti-HBV Data at CROI 2026
Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at the 33rd Conference on Retroviruses and Opportunistic Infections (CROI), in Denver, CO,...
YolTech Reports Positive Interim Data on YOLT-202
Single dose of YOLT-202 led to rapid, robust and dose-dependent increases in AAT levels to normal range Single dose of YOLT-202 was well tolerated with...